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The notochord is an evolutionary novelty in vertebrates that functions as an important signaling center during
development. Notochord ablation in chicken has demonstrated that it is crucial for pancreas development;
however, the molecular mechanism has not been fully described. Here, we show that in zebrafish, the loss
of function of nog2, a Bmp antagonist expressed in the notochord, impairs b cell differentiation, compatible
with the antagonistic role of Bmp in b cell differentiation. In addition, we show that nog2 expression in the
notochord is induced by at least one notochord enhancer and its loss of function reduces the number of
pancreatic progenitors and impairs b cell differentiation. Tracing Nog2 diffusion, we show that Nog2 ema-
nates from the notochord to the pancreas progenitor domain. Finally, we find a notochord enhancer in human
and mice Nog genomic landscapes, suggesting that the acquisition of a Nog notochord enhancer occurred
early in the vertebrate phylogeny and contributes to the development of complex organs like the pancreas.
INTRODUCTION
The pancreas is an endoderm-derived organ that has several
crucial roles, among them, controlling levels of glucose in the
blood by producing insulin from b cells and aiding digestion by
secreting digestive enzymes to the digestive system. The
pancreas develops from a group of progenitor cells, originating
from the endoderm developing gut, under the control of signaling
pathways that determine its correct position and size (Prince
et al., 2017; Sakhneny et al., 2019). One of these determinant
signaling molecules is Bmp, which has various roles in pancreas
development. These roles include the regulation of pancreatic
size by controlling liver and pancreas fates, partly by restricting
the expression of pdx1, an important top hierarchical gene pre-
sent in pancreatic progenitor cells (Prince et al., 2017; Sakhneny
et al., 2019). In zebrafish, and according to this model, bmp2b
expressed and secreted from the lateral plate mesoderm gener-
ates a gradient at which high levels of Bmp2b restrict pancreatic
size, favoring liver fate and establishing the development of the
pancreas in a region aligned with the midline of the embryo
(Chung et al., 2008, 2010). In this context, Bmp signaling works
as negative regulator of pancreas development. Interestingly, it
has been long postulated that the notochord, located at the
midline of the embryo, dorsal to the pancreas, has a pro-pancre-
atic function (Prince et al., 2017; Sakhneny et al., 2019). Part of
these observations derive from studies in which the notochord
was surgically removed from chicken embryos, showing that in
its absence, pancreatic markers such as insulin were defectively
expressed, as well as early progenitor markers such as Pdx1
(Kim et al., 1997). These results suggest that a non-autonomous
signal must emanate from the notochord to induce pancreatic
fate. One possibility is that activin bBand fibroblast growth factor
2 (FGF2), expressed in the notochord, might have a role in
pancreatic induction via repression of SHH expression in the
endoderm (Hebrok et al., 1998). Nevertheless, ectopic pancre-
atic tissue is not observed in the endoderm of Shh mutant em-
bryos (Hebrok et al., 2000), suggesting that inhibition of Shh
signaling is permissive, rather than instructive, for pancreas
fate (McCracken andWells, 2012). A complementary hypothesis
to be addressed is the presence of a Bmp antagonist expressed
in the notochord that might be required for proper pancreatic in-
duction; however, little is known about how Bmp signaling is
modulated in the endoderm to effectively determine pancreatic
size and position.
In zebrafish, one of the most notochord-specific Bmp antago-
nists is Noggin2 (Nog2) (F€urthauer et al., 1999). nog2 starts to be
expressed by the end of gastrulation (10 h post-fertilization [hpf])
in the zebrafish axial mesoderm, which shortly gives rise to the
notochord (F€urthauer et al., 1999). This expression is maintained
up to the 18-somite stage (16 hpf), when the transcript slowly
starts to disappear, and persists until 30 hpf in the posterior tip
of the notochord. In this work, we disrupted the function of
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nog2, observed consistent impairment in the number of pancre-
atic progenitor cells and insulin-expressing cells, and showed
nog2 to be an important Bmp antagonist required for pancreatic
development. The introduction of an enhancer blocking insulator
(Bessa et al., 2014) downstream of nog2 also impaired b cell dif-
ferentiation and reduced the number of pancreatic progenitor
cells, suggesting the existence of an enhancer required for the
nog2 pancreatic function. By analyzing histone modifications
associated with enhancer activity (histone H3 lysine 27 acetyla-
tion [H3K27ac] and histone H3 lysine 4 monomethylation
[H3K4me1]) (Bogdanovic et al., 2012; Marlétaz et al., 2018;
Rada-Iglesias et al., 2011) and performing circular chromosome
conformation capture coupled with next-generation sequencing
(4C-seq) (Zhao et al., 2006), we identified a nog2 notochord
enhancer, among others. To further demonstrate that the noto-
chord enhancer is crucial for the nog2 pancreatic function, we
targeted it using CRISPR-Cas9, inducing genomic deletions (Le-
telier et al., 2018); complementing these assays, we used Cas9
endonuclease dead (dCas9) fused to a KRAB repressor domain
(dCas9KRAB) (Thakore et al., 2015) and observed b cell differen-
tiation impairment. Moreover, in heteroallelic mutant embryos for
partial deletion of the notochord enhancer, we observed a
reduced number of pancreatic progenitor cells and b cells
when performing immunostaining for Nkx6.1 and insulin, respec-
tively. In addition, we traced Nog2 in vivo and observed its diffu-
sion from the notochord to the pancreatic progenitor domain,
supporting its non-autonomous function in pancreas develop-
ment. To understand whether this mechanism could also be
present in mammals, we explored the human and mouse Nog
regulatory landscapes, identifying notochord enhancers. Over-
all, these results suggest that Nog has acquired a notochord
enhancer, most likely in the basis of the vertebrate phylogeny,
that contributes to the crucial function of the notochord as an
important signaling center for the development of complex or-
gans such as the pancreas.
RESULTS
nog2 Controls Non-autonomously the Embryonic
Endocrine Pancreas Size
nog2 encodes a zebrafish Bmp antagonist that starts to be ex-
pressed at 10 hpf in the primordium of the notochord (F€urthauer
et al., 1999). To identify possible non-coding genetic modifica-
tions affecting pancreas development, we mobilized a transpos-
able element containing a potent enhancer blocking insulator
(Bessa et al., 2014).We found a novel integration of this construct
(ED301) located 2 kbdownstreamof nog2 (nog2ED301) (Figure 1A;
Figure S1). Homozygous embryos for this integration showed a
decrease of nog2 expression at 10 hpf that was detected by
qPCR (Figure 1B). To determine whether the downregulation of
nog2 could affect pancreas development, we performed in situ
hybridization for insulin and determined that its area of expres-
sion was reduced in nog2ED301 homozygous embryos (Figures
1C and 1D) compared with control embryos. Next, to determine
whether the phenotype observed in pancreas development was
caused by the action of the insulator, we injected Cre recombi-
nase in homozygous embryos for the nog2ED301 integration and
performed in situ hybridization for insulin. Cre recombinase tar-
geted two loxP cassettes flanking the insulator in the ED301
construct (Figure 1A). In this experimental condition, we
observed a rescue of the decreased area of insulin expression
(Figure 1D). These results suggest that the ectopic insulatormight
be blocking a cis-regulatory element of nog2 required for proper
pancreas development. To validate nog2 as an important gene
controlling pancreas development, we generated a nog2mutant
line (nog2mut) using the CRISPR-Cas9 targeting system. This
mutant line shows a frameshift mutation in the nog2 gene (Fig-
ure S2A). Although nog2 is not expressed at the shield develop-
mental stage, when the dorsal/ventral axis of the zebrafish em-
bryo is established by a ventral gradient of Bmp, it is known
that ectopic expression of nog2 interferes with Bmp signaling,
causing dorsalization phenotypes (F€urthauer et al., 1999). There-
fore, to test whether the nog2mut frameshift mutation is a loss of
function of the nog2 gene, we injected mRNA of the frameshift
version of nog2 in zebrafish embryos.We did not observe a dors-
alization phenotype, contrasting the wild-type (WT) version of
nog2 mRNA (Figures S2C and S2D). These results show that
nog2mut is most likely a null mutant for nog2. We incrossed
nog2+/mut, generating a mixture of WT, heterozygous, and
homozygous embryos, and outcrossed nog2+/mut with
nog2ED301/ED301. In both cases, the resulting embryos had a sig-
nificant decrease in the area of expression of insulin, demon-
strating that nog2 is required for the differentiation of a correctly
sized pancreas (Figure 1D). The decrease of the area of
Figure 1. nog2 Is Required for Proper Pancreas Development
(A) ED301 zebrafish line corresponds to an ED transposon integration containing a potent enhancer blocking insulator (yellow) and mapped 2 kb downstream of
nog2. The loxP sequences are depicted as black triangles (see also Figure S1). Scale bar represents 2 kilobases.
(B) In the ED301 zebrafish line, nog2 expression is downregulated, as detected by qPCR performed in three biological replicates of 30 embryos each (error bars
represent SD; *p < 0.05).
(C) In situ hybridization of insulin in 48 hpf representative embryos from an outcross of nog2ED301/ED301 and nog2+/mut lines compared with control embryos. Scale
bar represents 80 mm.
(D) Quantification of the insulin expression area detected by in situ hybridization in control (n = 194), nog2 ED301/ED301 (n = 93), nog2ED301/ED301 injected with Cre
recombinase (n = 32), nog2+/mut incross (n = 115), and nog2ED301/ED301, nog2+/mut outcross embryos (n = 36) at 48 hpf. Error bars represent SD; ****p < 0.0001.
(E) Representative confocal images of 48 hpf zebrafish embryos counterstained with a DAPI nuclear marker (blue), an anti-insulin antibody marking b cells (red),
and an anti-Nkx6.1 antibodymarking pancreatic progenitor cells (green). Images represent themaximum-intensity z projection of several focal planes obtained in
a Leica Sp5 confocal microscope using a 403 objective. Scale bars represent 20 mm.
(F) Quantification of the number of insulin-expressing cells in nog2ED301/ED301 and nog2ED301/ED301, nog2+/mut outcross embryos compared with controls (nR 30).
Error bars represent SD; ****p < 0.0001, **p < 0.01.
(G) Quantification of the number of nkx6.1-expressing cells in nog2 ED301/ED301 and nog2ED301/ED301, nog2+/mut outcross embryos compared with controls
(n R 18). Error bars represent SD; ****p < 0.0001, ***p < 0.001.




expression of insulin could be caused by a decrease in the num-
ber of b cells or by a decrease in their size. To discriminate be-
tween these two possible scenarios, we injected a morpholino
against nog2 in a transgenic reporter line for insulin expression
(diIorio et al., 2002) and observed a reduced number of b cells
in the nog2 morpholino-injected animals (Figures S2E and S2F).
In addition, we performed immunostaining for Nkx6.1, to label
pancreatic progenitor cells, and for insulin, to label differentiated
bcells, in homozygous embryos for thenog2ED301 integration.We
observed that the numbers of both Nkx6.1 and insulin cells
decreased compared with controls. A similar decrease in the
average number of Nkx6.1- and insulin-expressing cells was
also detected in a 50% mixed population of embryos carrying
the heteroallelic combination of nog2ED301/mut and nog2+/ED301
(Figures 1E to 1G). These results suggest that the reduced num-
ber of insulin-expressing cells might be the consequence of a
smaller pancreatic progenitor domain, indicating that nog2 is
required for the development of a properly sized pancreas.
nog2 Genomic Regulatory Landscape Contains a
Notochord-Specific Enhancer
Nogproteins arewell-knowndiffusiblemolecules that act asBmp
antagonists (Inomata et al., 2013). nog2 function in pancreas
Figure 2. nog2 Genomic Regulatory Land-
scape Contains a Notochord-Specific
Enhancer
(A) Genomic landscape of nog2, represented in
the University of California Santa Cruz Genomics
Institute (UCSC) genome browser (Kent et al.,
2002), comprising more than 100 kb. The black
track represents chromatin interaction points de-
tected by 4C-seq using the nog2 promoter as the
viewpoint (red asterisk). Scale bar represents 25
kilobases.
(B) Zoom-in in the locus of nog2 comprising
approximately 25 kb. Representation of the
ED transposon integration 2 kb downstream
of nog2. Purple (top), brown (middle), and
blue (bottom) tracks represent the ATAC-seq
and chromatin immunoprecipitation sequencing
(ChIP-seq) signal for H3K27ac and H3K4me1,
respectively, at three developmental times: 24 hpf,
80% epiboly (80 epi), and dome. The black track
represents the 4C-seq signal at 24 hpf using the
nog2 promoter as the viewpoint. Pale blue boxes
highlight selected sequences for enhancer activity
assays (E1 to E3). Two replicates of 4C data are
shown in Figure S3. Scale bar represents 5 kilo-
bases.
(C) Representative images of GFP reporter lines
for enhancers E1 to E3 (see also Figure S1). Scale
bars represent 100 mm.
development might be explained by its
expression in the notochord and subse-
quent diffusion to the endoderm, which
has a non-autonomous, pro-pancreatic
role. The nog2ED301 zebrafish line con-
tains an insulator integration in the
genomic landscape of nog2 that causes
its transcriptional downregulation. This leads us to postulate
that an essential enhancer for the nog2 pancreatic function
should be present in the nog2 regulatory landscape, downstream
of the insulator integration. To identify the possible cis-regulatory
element that might be triggering the expression of nog2 in
the notochord, we analyzed the landscape of nog2, looking for
regions of open chromatin, as determined by Assay
for Transposase-Accessible Chromatin using sequencing
(ATAC-seq), and enriched for H3K27ac and H3K4me1, two his-
tone marks associated with enhancer activity (Figures 2A and
2B). Because these histone modifications probably occur before
the onset of nog2 expression, starting in the notochord at 10 hpf,
we lookedat histonemarks at thedevelopmental stagesof dome,
80%epiboly, and 24 hpf (Bogdanovic et al., 2012;Marlétaz et al.,
2018). In addition,weperformed4C-sequsing thenog2promoter
as the point of view to identify the subset of putative cis-regulato-
ry sequences that interact with the promoter of nog2 and there-
fore belong specifically to the regulatory landscape of this gene
(Figure S3A). Using these strategies, we defined 3 putative
nog2 enhancers (Figure 2B, E1 to E3). We performed enhancer
transgenesis assays for these sequences and verified that all 3
sequences are enhancers, together recapitulating the early
expression pattern of nog2 (Figure 2C; Figure S1E). Of the 3




sequences, E3was shown tobeastrongnotochord enhancer; E2
was shown to be is a forebrain, hindbrain, and somite enhancer;
and E1 was shown to be a strong ventral forebrain enhancer
(Figure 2C).
Next, we wanted to address whether nog2 can diffuse from
the notochord to the pancreatic progenitor domain. To test
this, first we built a construct containing a Nog2-encoded pro-
tein fused to GFP. To test whether the GFPNog2 fusion pro-
tein maintained its functionality, we injected GFPnog2 mRNA
in 1-cell-stage embryos and observed the presence of dorsal-
ization phenotypes, as in the case of WT nog2 mRNA (Figures
S2C and S2D). Then, we built a transposable element contain-
ing the nog2E3 notochord enhancer and a minimal promoter
upstream of GFPnog2 (nog2E3:GFPnog2) to be able to track
Nog2 diffusion (Figure 3A; Figure S2B). Upon injection of ze-
brafish embryos with this construct and Tol2 mRNA, we per-
formed staining using an anti-Nkx6.1 antibody that labels
pancreatic progenitor cells (Binot et al., 2010; Hesselson
et al., 2011). We observed clear colocalization of GFP aggre-
gates in the pancreatic progenitor domain (Figure 3A) in 16 of
20 embryos (80%), as analyzed by confocal microscopy,
showing that Nog2 can diffuse from the notochord to the
pancreatic field in the endoderm. These results contrast those
of controls expressing only GFP (Figure 3B), in which GFP ag-
gregates were not seen outside of the notochord in 18
analyzed embryos. These results help to explain the non-
autonomous effect observed in the pancreas in the nog2
loss-of-function assays.
Figure 3. Nog2 Diffuses from the Notochord to the Pancreatic Progenitor Domain
(A) Representative confocal image of a 18 hpf zebrafish embryo injected with the nog2E3:GFPnog2 construct. Of 20 embryos, 16 (80%) showed colocalization of
GFPNog2 aggregates (green) with pancreatic progenitor cells, labeled with anti-Nkx6.1 antibody (white). Details of the colocalization can be observed in the inset
(white box).
(B) Representative confocal image of a 18 hpf zebrafish embryo injected with nog2E3:GFP (control), in which the pattern of GFP expression (green) is restricted to
the notochord. None of 18 analyzed embryos displayed colocalization of GFP aggregates with Nkx6.1-labeled cells. Embryos were counterstained with the
nuclear marker DAPI (blue), and the endocrine progenitor domain is delimited by a yellow dashed line (see also Figure S2). Images represent the maximum-
intensity z projection of several focal planes obtained in a Leica Sp5 confocal microscope using a 403 objective. Scale bars represent 30 mm.




Figure 4. The nog2 Notochord Enhancer Is Required for Proper Pancreas Development
(A) Representation of the WT nog2E3 enhancer (above) and somatic deletions (below) generated by the injection of the Cas9 protein, together with sg1 and sg2
targeting two regions of the sequence 237 bp apart (see also Figure S3).
(B) In situ hybridization of insulin in 48 hpf representative embryos, injected with the Cas9 protein, and two sgRNAs compared with control embryos, injected with
only Cas9. Scale bars represent 80 mm.
(C) Quantification of the insulin expression area detected by in situ hybridization in injected embryos at 48 hpf compared with controls. Error bars represent SD;
****p < 0.0001. In all cases, n R 97.
(D) Diagram of the nog2E3:GFPnog2 construct used to achieve notochord-specific overexpression of GFPnog2 and the respective control.
(E) In situ hybridization of insulin in 48 hpf representative embryos injected with nog2E3:GFPnog2 compared with control embryos. Scale bars represent 80 mm.
(legend continued on next page)




The nog2 Notochord Enhancer Is Required for Proper
Pancreas Development
The nog2E3 notochord enhancermost likely controls the expres-
sion of nog2 in the notochord and is required for pancreatic
development. To address this hypothesis, we synthetized a
pair of single-guide RNAs (sgRNAs) 237 bp apart (nog2E3 sg1
and sg2) to target the nog2E3 notochord enhancer and generate
genomic deletions for this cis-regulatory sequence. Embryos in-
jected with Cas9 and the combination of nog2E3 sg1 and sg2
showed somatic deletions (Figure 4A; Figures S3E–S3G). In
situ hybridization for insulinwas performed in these injected em-
bryos, together with controls injected with Cas9 alone, and the
area of insulin expression was measured. We observed a
decreased area of insulin expression for nog2E3 sg1 and sg2
(Figures 4A–4C). To validate these results, we injected a combi-
nation of nog2E3 sg1 and sg2 with dCas9-KRAB (Thakore et al.,
2015). When compared with control embryos injected with
dCas9-KRAB alone, we observed a reduction in the area of insu-
lin expression (Figures S3B–S3D), suggesting that the nog2E3
notochord enhancer is modulating the expression of nog2 in
this tissue and is required for proper pancreas development.
Indeed, partial deletion of the nog2E3 notochord enhancer
shows a tendency for decreased nog2 expression (Figure S4).
Furthermore, we observed a decrease in the average number
of Nkx6.1- and insulin-expressing cells in homozygous embryos
for this deletion (Figures 4G–4I), recapitulating the phenotype
seen in the nog2ED301 integration mutants. Accordingly, ectopic
expression of nog2 in the notochord should result in increased
pancreas size. To test this, we injected the nog2E3:GFPnog2
construct and measured the size of the area of expression of in-
sulin, noticing an incremental change in the pancreatic field area
(Figures 4D–4F). These results demonstrate that the nog2E3
notochord enhancer is required for the proper function of nog2
in pancreatic development and to establish a correctly sized
pancreas.
The Expression of Nog in the Notochord Is Conserved in
Vertebrates and Is Mediated by Equivalent Notochord
Enhancers
Next, we wanted to understand whether NOG expression in hu-
mans could be controlled by a notochord enhancer. To clarify
this, we screened the human NOG genomic landscape for puta-
tive enhancers, based on sequence conservation and SNPs
associated with type 2 diabetes and hyperglycemic traits (Fig-
ure 5A) (Morris et al., 2012). We selected 9 candidate human se-
quences (D12 to D10) (Figure 5A) to perform enhancer reporter
assays in zebrafish and determined whether any of these se-
quences is a notochord enhancer. Preliminary results obtained
by the generation of mosaic zebrafish transgenic embryos
showed that sequence D10 was able to drive expression of
GFP in the notochord (Figure S5D). We confirmed this result by
generating stable zebrafish transgenic reporter lines for the
selected sequences (Figure 5A). Apart from the D10 notochord
enhancer, we found that D5 is a somite, forebrain, and hindbrain
enhancer; D6 is a forebrain and somite enhancer; and D9 has
broad enhancer activity and does not show high tissue speci-
ficity (Figure 5B; Figures S5A–S5D). Enhancers D5, D6, D9,
and D10 were confirmed and obtained concordant expression
patterns in at least two independent genomic integrations of
the reporter constructs (Figures S5A–S5D). Sequences D7,
D11, and D12 showed unreproducible patterns, and D12 and
D8 showed no expression of the reporter gene. The expression
patterns of the different human enhancers correlate with the
known expression of Nog in mice, chicken, and Xenopus (Fig-
ure S5E), including the notochord and nervous system, suggest-
ing that the Nog vertebrate genomic landscape has functionally
similar cis-regulatory elements.
We were able to align the human D10 enhancer with the
genome of other mammal species, suggesting that this cis-reg-
ulatory element is conserved. The most distantly related species
with which D10 can be aligned are two representatives of marsu-
pials, opossum (Monodelphis domestica) and Tasmanian devil
(Sarcophilus harrisii), that diverged from humans around 180
million years ago (Figure S5F). Interestingly, in four analyzed
cases—mouse, dog, armadillo, and opossum—the D10 ortholog
sequences are always found in synteny with the respective Nog
ortholog genes (Figures S6A and S6B), suggesting that these
conserved sequences belong to the regulatory landscape of
Nog. Furthermore, looking at HiC data from human and mouse
tissues, it is possible to appreciate that NOG and D10 enhancer,
as well as the corresponding mouse ortholog sequences, are
within the same topologically associating domain (TAD) (Dixon
et al., 2012) in a genomic region enriched for chromatin interac-
tions (Figures S6C–S6F). Next, we wanted to understand
whether the conserved D10 orthologs correspond to notochord
enhancers. Inmice, the D10 ortholog sequence is located 157 kb
downstream of Nog (Figure 5C). We isolated this sequence,
tested it for enhancer activity using reporter assays, and demon-
strated that this sequence is also a notochord enhancer (Fig-
ure 5D). Overall, these results suggest that the regulatory mech-
anism for the expression of Nog in the notochord might be
equivalent in many vertebrate lineages.
DISCUSSION
Non-autonomous cell signaling is crucial for proper organogen-
esis. It has been demonstrated that several signaling pathways
regulate pancreatic development in vertebrates. Among them,
Hedgehog signaling represses the expression of the pancreatic
multipotent progenitor marker Pdx1 during late gastrulation
(F) Quantification of the insulin expression area detected by in situ hybridization in injected embryos at 48 hpf compared with controls. Error bars represent SD;
***p < 0.001. In all cases, n R 38.
(G) Representative confocal images of 48 hpf zebrafish embryos counterstained with a DAPI nuclear marker (blue), an anti-insulin antibody marking b cells (red),
and an anti-Nkx6.1 antibodymarking pancreatic progenitor cells (green). Images represent themaximum-intensity z projection of several focal planes obtained in
a Leica Sp5 confocal microscope using a 403 objective. Scale bars represent 20 mm.
(H) Quantification of the number of insulin-expressing cells in nog2E3del1/del2 embryos compared with controls (n R 19). Error bars represent SD; *p < 0.05.
(I) Quantification of the number of nkx6.1-expressing cells in nog2E3del1/del2 embryos compared with controls (n R 13). Error bars represent SD; ***p < 0.001.




(Tehrani and Lin, 2011). In mice, activin bB and Fgf2 expressed in
the notochord might repress Shh expression in the endoderm
(Hebrok et al., 1998). However, ectopic pancreatic tissue is not
observed in Shhmutant embryos (Hebrok et al., 2000), suggest-
ing that Shh inhibition is permissive, rather than instructive, for
pancreas fate (McCracken and Wells, 2012). Experiments of
notochord ablation in chicken embryos showed that pancreatic
development is impaired (Kim et al., 1997). These results high-
light the notochord as an important signaling center for pancre-
atic development. In subsequent experiments using coculture of
mice tissues, it has been shown that the notochord is sufficient to
trigger expression of Pdx1 in the endoderm, but not Insulin,
whereas cells from the dorsal aorta are able to trigger the expres-
sion of Pdx1 and Insulin. These results further suggest that the
notochord and the dorsal aorta have a role in the control of
pancreas progenitor cells, whereas aorta endothelial cells have
an extra role in the differentiation of b cells (Lammert et al.,
2001). Here we show that Nog is expressed in the notochord,
controlled transversely in humans, mice, and zebrafish by at
least one notochord enhancer, and that nog2 gain and loss of
function in zebrafish correlate with an increase and a decrease
of pancreatic differentiation, respectively. In addition, we show
that Nog2 diffuses from the notochord to the pancreatic domain,
as detected indirectly by an ectopic expression system (Fig-
ure 3). These results indicate that Nog is one of the crucial pro-
pancreatic signaling molecules emanating from the notochord.
In agreement with this, Nog is a well-known Bmp signaling inhib-
itor (F€urthauer et al., 1999), and this signaling pathway is known
to antagonize pancreas differentiation (Chung et al., 2008, 2010)
while promoting liver differentiation. In this model, the Bmp2b
Figure 5. The Expression of Nog in the Notochord Is Conserved in Vertebrates and Is Mediated by Equivalent Notochord Enhancers
(A) Genomic landscape of human NOG, comprising approximately 150 kb. Black vertical lines represent SNPs associated with diabetes from the Diabetes
Genetics Replication and Meta-analysis (DIAGRAM) Consortium (p < 0.02) (Morris et al., 2012; Pasquali et al., 2014). The dark blue track represents vertebrate
conservation and showsmultiple alignments of 100 vertebrate species andmeasurements of evolutionary conservation (phyloP) (Pollard et al., 2010). Dashed line
boxes are putative enhancer sequences selected for enhancer assays. Sequences in pale blue shaded boxes showed reproducible expression patterns. D10
(green shaded box) showed enhancer activity in the notochord. Scale bar represents 50 kilobases.
(B) Representative images of GFP reporter lines for enhancers D5, D6, D9, and D10 (see also Figure S5). Scale bars represent 100 or 200 mm.
(C) Genomic landscape of the human D10 sequence, showing vertebrate (blue track) and mouse conservation (green track) (above). Genomic landscape of
mouse Nog, including the conserved mouse D10 (mD10) sequence, located approximately 150 kb downstream of the promoter (see also Figures S5 and S6).
Scale bars represent 500 basepairs or 50 kilobases.
(D) Representative image of the GFP reporter line for the mouse enhancer mD10. Scale bar represents 100 mm.




gradient emanating from the lateral plate mesoderm is not
enough for the establishment of a proper pancreatic progenitor
domain by control of the expression of pdx1. Nog2 from the
notochord, located in the midline, counteracts the lateral
signaling of Bmp2b, allowing the proper placement and proper
size of the pancreatic progenitor domain in the midline (Figure 6).
In absence of Nog2 from the notochord, Bmp2b signaling is
most likely expanded, resulting in a reduced pancreatic progen-
itor domain that will cause partial impairment of b cell develop-
ment (Figure 6). These phenotypes are recapitulated by impair-
ing a nog2 notochord enhancer, either by the action of an
insulator or by the deletion of the enhancer. Nevertheless, in
these genetic backgrounds, the downregulation of nog2 is
more robustly detected in the insulator background, suggesting
the existence of several notochord enhancers or that partial
deletion of the enhancer results in partial loss of expression of
nog2. In both cases, knockdown of nog2 is sufficient to induce
a pancreatic phenotype.
Although nog2 has a clear pro-pancreatic role during zebrafish
development, null mutants for nog2 do not show complete loss
of pancreas differentiation. Chicken notochord ablation has
been shown to induce complete loss of pancreatic differentiation
(Kim et al., 1997). Therefore, it is possible that apart from nog2,
there might be synergistic action with other pro-pancreatic
signaling molecules diffusing from the notochord.
In this work, we postulate that the function of NOG is
conserved in humans. Supporting this, the genomic landscape
of NOG contains a notochord enhancer, clearly showing the po-
tential of this gene to be expressed in these cells. A study of the
human notochordal transcriptome during embryogenesis was
able to detect NOG expression during development (Ro-
drigues-Pinto et al., 2018), specifically at a late developmental
Figure 6. Proper Pancreas Development
Requires the Expression of Nog2 in the
Notochord
(A) Diagram of the nog2 notochord enhancer
driving expression of nog2. Nog2 diffusion from
the notochord, located in the midline of the em-
bryo, counteracts the signaling of Bmp2b from the
lateral plate mesoderm, allowing the proper
placement and proper size of the endocrine
pancreas.
(B) When the activity of the nog2 notochord
enhancer is disrupted, nog2 expression in the
notochord is reduced. In this case, Bmp2b
signaling is expanded, impairing b cell develop-
ment and reducing pancreas size.
time in human pancreatic formation.
This interpretation is strengthened by ad-
vances in in vitro differentiation of human
b cells from human embryonic stem cells.
Optimization protocols have empirically
determined that the addition of NOG
was able to improve the efficiency of
such protocols, clarifying the importance
of BMP inhibition in the proper develop-
ment of the human pancreas (Kroon et al., 2008; Kumar et al.,
2014; Mfopou et al., 2010; Zhang et al., 2009). Cai and col-
leagues explored the role of NOG in human b cell differentiation,
showing that the inclusion of NOG in the media resulted in inhi-
bition of phosphorylation of Smad1/5/8, a BMP signaling trans-
ducer (Cai et al., 2010). From an evolutionary point of view, it is
known that the vertebrate phylum contains at least three distinct
Nog genes: Nog1, Nog2, and Nog3 (Eroshkin et al., 2006). In
mammals, onlyNog1was kept, most likely retaining all functions
and expression patterns of the three ancestral genes from the
vertebrate phylum. An interesting open question relates to the
emergence of the cis-regulatory module of the notochord that
in humans and mice is present in the landscape of Nog, the or-
tholog of the zebrafish nog1, whereas in zebrafish, the notochord
enhancer is present in the landscape of nog2. This could be ex-
plained by the independent recruitment of recently evolved noto-
chord enhancers, as observed in the rapid evolution of cis-regu-
latory sequences of the mammal liver (Villar et al., 2015). An
alternative explanation could be the existence of an ancestral
regulatorymodule driving the expression ofNog in the notochord
that upon gene duplication degenerated in particularNog genes.
In the tetrapod lineage, the notochord cis-regulatory elements
were most likely kept in the landscape of Nog1, a scenario sup-
ported by (1) the high conservation of the enhancer from humans
to marsupials (Figure S6), (2) the expression of Nog1 in the noto-
chord from humans to Xenopus (Figure 5; Figure S5), and (3) the
functional characterization of the mice and human Nog noto-
chord enhancers. In contrast, the existence of the notochord
enhancer in the landscape of zebrafish nog2 suggests that this
enhancer was kept in this locus in the ray-finned fish lineage.
Most likely, the acquisition of the Nog notochord enhancer
occurred after the divergence of urochordates, because




expression of Nog is not detected in the sea squirt Ciona intesti-
nalis or in a cephalochordate, the amphioxusBranchiostoma lan-
ceolatum. Interestingly, insulin-producing cells in basal cephalo-
chordates are not organized in a distinct organ and are instead
disseminated in the gut (Arntfield and van der Kooy, 2011).
Finally, and in light of the axochord hypothesis (Brunet et al.,
2015), the Nog notochord enhancer might have an even more
ancient origin. Supporting this hypothesis, the annelids Terebra-
talia transversa and Platymeris dumerilii show expression of Nog
in the axochord, a structure reminiscent of the notochord that
has a mixture of muscle and notochord double properties (Lauri
et al., 2014; Passamaneck et al., 2015).
In summary, in this work, we demonstrate the transversal ex-
istence of a notochord enhancer in humans, mice, and zebrafish
in the landscape of Nog, a known Bmp antagonist. We show that
this enhancer is required for proper pancreas differentiation in
the zebrafish, contributing to understanding of the notochord
as an important signaling center required for the complex devel-
opment of the vertebrate pancreas.
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Materials Availability
All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer
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Data and Code Availability
Raw reads from 4C experiments (fastq files of the 2 replicates) are accessible in the European Nucleotide Archive (ENA, https://www.
ebi.ac.uk/ena, project PRJEB36984, study ERP120260, runs ERR3964955 and ERR3964956). The processed signal is available for
visualization in the following UCSC genome browser session http://genome-euro.ucsc.edu/s/vdr/danRer7_4Cseq_nog2. Perl script
for processing 4C seq data is available upon request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish
Zebrafish (Danio rerio) fish were handled according to European animal welfare regulations and standard protocols. The Animal Fa-
cility of the i3S is licensed by the Portuguese official veterinary department (DGAV) and accredited by the AAALAC (June, 2018), com-
plies with Portuguese law (Portaria 1005/02 and Portaria 1131/97), the 2010/63/EU Directive, and follows the FELASA (Federation of
European Laboratory Animal Science Associations) guidelines and recommendations concerning laboratory animal welfare. The
current project is licensed by DGAV (reference: 0421/000/000/2016). Wild-Type (WT) zebrafish animals from AB or TU strain were
used in this study. The following genotypes were used, as described in the text and Key Resources Table: nog2ED301, nog2mut,
nog2E3del1/del2, Tg (Ins:GFP), nog2E1:GFP, nog2E2:GFP, nog2E3:GFP, NOGD10:GFP, NOGD5:GFP, NOGD9:GFP and mD10:GFP.
Adult animals are kept at a controlled temperature (25C) and under a 14h light-8h dark photoperiod. Recirculated water is contin-
uously monitored regarding pH (7), salinity (900 ms) and temperature (28C) values. In order to obtain zebrafish embryos, adult zebra-
fish were bred in ratios of 3 females to 2 males or 1 male to 1 female, depending on the purpose of the experiment. Embryos ranging
from 16hpf to 48hpf were used.
METHOD DETAILS
Zebrafish transgenesis
ED301 line was generated as described by Bessa et al. (2014). Enhancer reporter assays were performed by cloning the selected
genomic fragments into the ZED vector (Bessa et al., 2009). For the mouse sequence mD10 only, the pminiTol2- Z48-Gw-CARGFP
vector was used (Bessa et al., 2009). Briefly, genomic regions of interest were PCR amplified using iMAXII polymerase and specific
primers (Table S1). TA cloning was used to introduce PCR products in the pCR8/GW/TOPO vector, as described in the pCR8/GW/
TOPO TA Cloning Kit (ThermoFisher Scientific). To clone these sequences in the destination vectors, the Gateway LR Clonase II
Enzymemix (ThermoFisher Scientific) and respective protocol was used. Vectors where purified using phenol:cloroform and injected
in one-cell-stage zebrafish embryos (AB strain), together with mRNA encoding Tol2 protein, in a 1:1 ratio and a final concentration of
25 ng/ul each. Injected embryos showing reporter expression were grown to adulthood and germinal line transmission was deter-
mined by outcrossing injected fish with wild-type animals and isolating F1 embryos with GFP expression. Embryos were kept in
E3 medium with 0.003% 1-phenyl-2-thiourea (SigmaAldrich) to prevent pigmentation and were staged according to Kimmel et al.
(1995). Embryos showing GFP expression were anesthetized by adding tricaine (ethyl -3-aminobenzoate; SigmaAldrich) to the E3
medium, and expression patterns were documented at 18-24 hpf, using the Leica M205 stereomicroscope. Post-imaging analysis
was done in Fiji-ImageJ (Schneider et al., 2012). Stable transgenic lines were selected to grow and maintained by outcrossing with
wild-type animals.
Genomic DNA extraction
Batches of embryos were incubated with Chelex 100 sodium form resin (Sigma #C7901 25 gr) 5% in TE buffer and with proteinase K
1 mg/mL (ThermoFisher Scientific), at 56C for 3 hours. After that, proteinase K activity was inactivated by incubating the samples at
100C for 10 minutes.
Cas9 targeting, sgRNA synthesis, mutant generation
The sgRNAs targeting the coding regions of nog2 and the regions flanking nog2E3 (Table S1) were designed using the Crisprscan
software (MorenoMateos et al., 2015). These oligonucleotides were annealed in vitro by denaturation at 95C for 5 min followed
by slow cooling at RT. Annealed oligonucleotides (1:10) were further inserted into 100ng of pDR274 vector (Hwang et al., 2013;




Addgene plasmid #42250) previously cut with BsaI (Anza, ThermoScientific). pDR274 vectors carrying sgRNA sequences were line-
arized with HindIII, purified with phenol:chloroform and transcribed with T7 RNA polymerase (ThermoFisher Scientific). sgRNAs were
purified following the mRNA purification protocol previously described (Bessa et al., 2009). To achieve nog2 knockdown, one- cell-
stage zebrafish embrycos were injected with Cas9 protein (PNA Bio Inc) (150 250 ng/ul) and 1 sgRNA (80125 ng/ul), targeting the
coding region of nog2 (sg1nog2, Table S1). To perform the nog2E3 enhancer knockdown, embryos were coinjected with a mixture
containing a combination of either Cas9 protein or dCas9-KRAB mRNA and 2 sgRNAs (80125 ng/ul each) (sg1E3, sg2E3, Table S1).
In both cases, zebrafish mutants for nog2E3 were generated using the combination of sgRNA1 and sgRNA2. Enhancer deletion in
zebrafish was detected by PCR with HOT FIREPol DNA Polymerase (Solis BioDyne) using primers flanking the region of interest
(see Figure S3 and Table S1). PCR product was analyzed by electrophoresis in 2% agarose gel, and further confirmed by Sanger
sequencing. Injected embryos were grown and adult fish fins were cut to perform genomic DNA extraction and genotyping as
described above (see Figure S4 and Table S1). One heterozygous male and one female having similar deletions were selected
and crossed. Embryos were genotyped by fin clipping and genomic DNA extraction, followed by PCR amplification using the primers
depicted in Table S1 (see also Figure S4).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed on zebrafish embryos staged according to Kimmel et al. (1995), using antisense
riboprobes targeting nog2 or insulin. nog2 probe was amplified from zebrafish cDNA, using the primers depicted in Table S1, and
cloned into pCR2.1-TOPO TA vector (ThermoFisher Scientific). A vector for generating an insulin-targeting probe was kindly sent
to us by Francesco Argenton (Argenton et al., 1999). Vectors were linearized using HindIII restriction enzyme (ThermoFisher Scien-
tific). Antisense RNA probes were synthesized, using T7 RNA polymerase (ThermoFisher Scientific) and digoxigenin-labeled nucle-
otides (Roche) and kept in ISH hybridization buffer (HYB+; Thisse et al., 1993). Zebrafish embryos were collected at 18 or 48hpf and
fixed overnight in 4% paraformaldehyde (PFA) in phosphatebuffered saline (PBS). Fixed embryos were washed in PBS-Tween 0.1%
(PBT) and dehydrated in methanol (MeOH), in a series of MeOH/PBT solutions. Dehydrated embryos were kept at 20C in 100%
MeOH. After this, embryos were rehydrated through a reverse MeOH/PBT series and then treated with proteinase K 1 mg/mL
(ThermoFisher Scientific), for 1–10 min. Embryos were washed in PBT, post-fixed in 4% PFA for 20 min and washed again in
PBT. Pre-hybridization was performed by incubating embryos in HYB+ buffer for 3 h, at 70C. After that, hybridization buffer was
replaced with solution containing riboprobes at the concentration of 2 ng/uL and an overnight incubation was performed, at 70C.
In the next day, embryos were washed with a series of solutions containing washing buffer (HYB-) and sodium saline citrate buffer
(SSC), as described by Thisse et al. (1993). Embryos were incubated for 1 h in blocking buffer, containing 2% normal goat serum
(ThermoFisher Scientific) and 2 mg/mL bovine serum albumin (BSA; Sigma-Aldrich). Following this, embryos were incubated for
2 h with anti-digoxigenin-AP antibody (Sigma-Aldrich) 1:5000, dissolved in blocking buffer. Several rinses in PBT were performed.
In the third day, embryos were washed with alkaline-phosphatase (AP) buffer (Thisse et al., 1993) and AP activity was revealed
through incubation in NBT/BCIP substrate (Sigma-Aldrich), in the dark, for at least 30 min. Embryos were rinsed in PBT to stop
the reaction and kept in 100% glycerol at 4C. Coloration associated to the presence of mRNA was observed and photographed,
using the Leica M205 stereomicroscope. Post-imaging analysis was done in Fiji-ImageJ.
Immunohistochemistry
Whole-mount immunohistochemistry was performed using mouse anti-rat nkx6.1 (Developmental Studies Hybridoma Bank) and
rabbit anti-insulin (abcam) antisera. Goat antimouse IgG AlexaFluor 488 (Invitrogen), goat anti-rabbit IgG AlexaFluor 568 (Invitrogen)
and goat anti-mouse IgG AlexaFluor 647 (Invitrogen) were used as secondary antisera. Briefly, embryos were fixed overnight in 4%
paraformaldehyde (PFA) in phosphatebuffered saline (PBS). Fixed embryos were sequentially washed with PBS Triton 0.1%, then
treated for 30 min to 2 h with PBS-Triton 1%, washed again with PBS-Triton 0.1% and incubated for 1h with PBS-T+BSA 5% before
the incubation with the primary antisera, diluted 1:50 in PBS-T+BSA, overnight at 4C. After extensive wash, embryoswere incubated
with the secondary antisera, overnight at 4C, washed extensively and mounted in 50% glycerol in PBS. Embryos were stained with
DAPI and 1,5 mm Z-series stacks were acquired on a Leica SP5 confocal microscope, using a 40x objective. Post-imaging analysis
and quantifications were done in Fiji-ImageJ.
Nog2 overexpression vector
The sequence encoding the signaling domain of the Nog2 protein was PCR amplified from zebrafish genomic DNA, using primers
carrying adaptor ends for BamHI and NcoI restriction enzymes. The mature encoding nog2 domain was amplified using 50EcoRI
and 30 XhoI restriction sites. The PCR products were sequentially cloned into pCS2GFP (Bessa et al., 2008) by restriction enzyme
cloning and the vector was sequenced. The nog2 signaling_GFP_mature nog2 sequence was introduced into the #237 pMEMCS
vector of the tol2 kit (Kwan et al., 2007), by BamHI/ XhoI cloning. The minimal promoter–E3 enhancer cassette was obtained by
BamHI/ SmaI digestion from the ZEDnog2E3 vector and cloned into the #228 p5EMCS vector of the tol2 kit. The generated #237
and #228 vectors were recombined with the #302 into the #394 destination vector using recombination driven by clonase II.





For the nog2 knockdown, 25 nL of 1 mM solution of morpholino targeting nog2 50UTR or Danio rerio standard control morpholino
(Table S1) (Gene tools, LLC) were injected in one-cell-stage Tg(ins:GFP) zebrafish embryos. Prior to the injection, morpholinos
were incubated at 65C for 10 min, vortexed, and diluted to 1mM in HyPure H20. Injected embryos were grown to 48 hpf and fixed
overnight at 4C in 4% paraformaldehyde in PBS. Fixed embryos were stained with DAPI and 1,5 mm Z-series stacks were acquired
on a Leica SP5 confocal microscope, using a 40x objective. GFP + cells were counted using Fij-ImageJ. Embryos from 3 independent
injections were analyzed for each condition.
Nog2 mRNA injections
25 nL of an 8 ng/uL solution of Nog2 WT or Nog2mut mRNAs were injected in one-cell-stage zebrafish embryos. Dorsalization phe-
notypes were observed and photographed around 24hpf, using the Leica M205 stereomicroscope. Post-imaging analysis was done
in Fiji-ImageJ.
4C-seq
4C-seq was performed according with Fernández-Miñán et al. (2016), with minor alterations. For each replicate, at least 200 24hpf
zebrafish embryos were collected. Embryos were fixed in 2% formaldehyde for 10 min, and stored at 80C. Cell lysis was performed
on ice, with a 15mL Tenbroeck Homogenizer, not exceeding 10min. Ligation was performed by using 60U T4 DNA Ligase (#EL0012,
ThermoFisher Scientific). Restriction enzymes used were DpnII (#R0543M, NEB) and Csp6I (#ER0211, ThermoScientific) for the first
and second cuts, respectively. Chromatin was purified by Amicon Ultra15 Centrifugal Filter Device (Milipore). 4C libraries were pre-
pared for Illumina sequencing by using Expand Long Template Polymerase (Roche) with primers targeting the TSSs of nog2 (Table
S1) and including Illumina adapters. Final PCR product was purified by High Pure PCR Product Purification Kit (Roche) and AMPure
XP PCR purification kit (Agencourt AMPure XP). 4C-seq libraries were first inspected for quality control using FASTQC v.0.11.5 (Data
S1) and demultiplexed using the script ‘‘demultiplex.py’’ from the FourCSeq package (Klein et al., 2015), allowing for 1 mismatch in
the primer sequence. A custom perl script was used for subsequent processing, as previously described (Noordermeer et al., 2011;
Splinter et al., 2012). Shortly, reads were aligned to the zebrafish genome (Zv9/danRer7) using Bowtie (Langmead et al., 2009), keep-
ing only uniquely mapping reads (v1.1.2, m 1). Reads within fragments flanked by restriction sites of the same enzyme, checked with
BedTools (Quinlan and Hall, 2010), or fragments smaller than 40 bp were filtered out. Mapped reads were then converted to read-
sperfirstenzymefragmentend units, and smoothed using a 30 fragment mean running window algorithm.
Quantitative PCR
Total mRNA was extracted from batches of 30 embryos or single embryos at 12 hpf with TRIzol (Invitrogen) and subsequent phenol:-
chloroform purification. Total mRNA was used for reverse transcription with random primers (SuperScript II, Invitrogen). Quantitative
PCR was performed on a BioRad CFX96 realtime system using Sybr (iSybr Green Supermix, BioRad), using the primers depicted in
Table S1. Each biological replicate was quantified in triplicates. eef1a and beta-actin or beta-actin alone were used as internal con-
trols, and expression levels were compared using the DDCT method.
QUANTIFICATION AND STATISTICAL ANALYSIS
Assuming that the data are normally distributed, an unpaired t-test with Welch’s correction was performed to test the significance of
differences among sample averages. For the comparison of nog2 relative expression between single embryos, a Mann-Whitney test
to compare ranks was used. Asterisks in each figure represent significance level: *p < 0.05, **p < 0,01, ***p < 0,001, n.s. = non-sig-
nificant. Statistics and plots were done using GraphPad Prism 6.
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